Singapore-based clinic management solutions Klinify announced on Wednesday that it has raised an undisclosed investment from healthcare services provider Zuellig Pharma.
The investment followed the startup’s previous US$604,000 funding round from Jungle Ventures, which it secured in February 2014.
Klinify plans to use the new funding for regional expansion and product development.
Through the partnership with Zuellig Pharma, Klinify has already entered the Malaysian market where it said to have been adopted by group practices with 22 clinics in the country.
It plans to expand to other countries where Zuellig Pharma has a presence, which includes Brunei Darussalam, the Philippines, Thailand, Indonesia, Vietnam, Cambodia, Myanmar, South Korea, Hong Kong, Macau and Taiwan.
According to Klinify Founder and CEO Krishanthan Surendran in a press statement, the partnership will provide the startup with reach and access to new customers and markets.
Klinify is also looking forward to develop its platform into a “one-stop shop” for doctors.
“We will do this by making existing Zuellig Pharma services such as product ordering and inventory management available through the application. This will make it easy for doctors to automate these processes, reducing the complexity of clinic management,” explained Zuellig Pharma Head of Strategy & Solutions Maarten Kelder.
The investment into Klinify is part of the company’s newly launched innovation centre in Singapore, where it plans to invest more than S$50 million (US$36 million) in the next five years.
Klinify was founded Surendran and Nishanth Sudharsanam, and was formerly known as Doctree.
It was incubated at JFDI.Asia in 2013, and has also raised fundings from Spring, NRF, and several angel investors in healthcare industry.
Image Credit: moniqcca / 123RF Stock Photo